These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38394616)

  • 1. Baseline Toxicity Model to Identify the Specific and Nonspecific Effects of Per- and Polyfluoroalkyl Substances in Cell-Based Bioassays.
    Qin W; Henneberger L; Glüge J; König M; Escher BI
    Environ Sci Technol; 2024 Apr; 58(13):5727-5738. PubMed ID: 38394616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.
    Evans N; Conley JM; Cardon M; Hartig P; Medlock-Kakaley E; Gray LE
    Toxicol Appl Pharmacol; 2022 Aug; 449():116136. PubMed ID: 35752307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of bioavailability and protein binding of four anionic perfluoroalkyl substances in cell-based bioassays for quantitative in vitro to in vivo extrapolations.
    Qin W; Henneberger L; Huchthausen J; König M; Escher BI
    Environ Int; 2023 Mar; 173():107857. PubMed ID: 36881956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health.
    Rogers JM; Heintz MM; Thompson CM; Haws LC
    Birth Defects Res; 2023 Jun; 115(11):1011-1062. PubMed ID: 37219003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Maternal, Fetal, and Postnatal Effects of Hexafluoropropylene Oxide Dimer Acid (GenX) from Oral Gestational Exposure in Sprague-Dawley Rats.
    Conley JM; Lambright CS; Evans N; Strynar MJ; McCord J; McIntyre BS; Travlos GS; Cardon MC; Medlock-Kakaley E; Hartig PC; Wilson VS; Gray LE
    Environ Health Perspect; 2019 Mar; 127(3):37008. PubMed ID: 30920876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.
    Nielsen G; Heiger-Bernays WJ; Schlezinger JJ; Webster TF
    Toxicology; 2022 Jan; 465():153024. PubMed ID: 34743024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Per- and polyfluoroalkyl substances (PFAS) in mixtures show additive effects on transcriptomic points of departure in human liver spheroids.
    Addicks GC; Rowan-Carroll A; Reardon AJF; Leingartner K; Williams A; Meier MJ; Moffat I; Carrier R; Lorusso L; Wetmore BA; Yauk CL; Atlas E
    Toxicol Sci; 2023 Jun; 194(1):38-52. PubMed ID: 37195416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure.
    Houck KA; Patlewicz G; Richard AM; Williams AJ; Shobair MA; Smeltz M; Clifton MS; Wetmore B; Medvedev A; Makarov S
    Toxicology; 2021 Jun; 457():152789. PubMed ID: 33887376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of in vitro methods in assessing human health risks associated with short-chain perfluoroalkyl and polyfluoroalkyl substances (PFAS).
    Solan ME; Lavado R
    J Appl Toxicol; 2022 Aug; 42(8):1298-1309. PubMed ID: 34873727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on toxicologically relevant gene expression profiles in a liver-on-a-chip model.
    Solan ME; Schackmuth B; Bruce ED; Pradhan S; Sayes CM; Lavado R
    Environ Pollut; 2023 Nov; 337():122610. PubMed ID: 37742859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the mode of action underlying development of liver lesions in mice following oral exposure to HFPO-DA and relevance to humans.
    Heintz MM; Haws LC; Klaunig JE; Cullen JM; Thompson CM
    Toxicol Sci; 2023 Mar; 192(1):15-29. PubMed ID: 36629480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS).
    Ehrlich V; Bil W; Vandebriel R; Granum B; Luijten M; Lindeman B; Grandjean P; Kaiser AM; Hauzenberger I; Hartmann C; Gundacker C; Uhl M
    Environ Health; 2023 Feb; 22(1):19. PubMed ID: 36814257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Transcriptomic Analysis of Human Primary Hepatocyte Spheroids Exposed to Per- and Polyfluoroalkyl Substances as a Platform for Relative Potency Characterization.
    Rowan-Carroll A; Reardon A; Leingartner K; Gagné R; Williams A; Meier MJ; Kuo B; Bourdon-Lacombe J; Moffat I; Carrier R; Nong A; Lorusso L; Ferguson SS; Atlas E; Yauk C
    Toxicol Sci; 2021 May; 181(2):199-214. PubMed ID: 33772556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a Framework for Grouping and Mixtures Toxicity Assessment of PFAS: A Closer Examination of Dose-Additivity Approaches.
    Goodrum PE; Anderson JK; Luz AL; Ansell GK
    Toxicol Sci; 2021 Jan; 179(2):262-278. PubMed ID: 32735321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model.
    Bangma J; Szilagyi J; Blake BE; Plazas C; Kepper S; Fenton SE; C Fry R
    Environ Toxicol; 2020 Dec; 35(12):1395-1405. PubMed ID: 32790152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for toxicity experiments and risk assessments with PFAS mixtures.
    McCarthy CJ; Roark SA; Middleton ET
    Integr Environ Assess Manag; 2021 Jul; 17(4):697-704. PubMed ID: 33749053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose Addition Models Accurately Predict the Subacute Effects of a Mixture of Perfluorooctane Sulfonate and Perfluorooctanoic Acid on Japanese Quail (Coturnix japonica) Chick Mortality.
    Gray LE; Conley JM; Bursian SJ
    Environ Toxicol Chem; 2024 Jan; 43(1):97-104. PubMed ID: 37753878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating mouse hepatic lipidome dysregulation following exposure to emerging per- and polyfluoroalkyl substances (PFAS).
    Kirkwood-Donelson KI; Chappel J; Tobin E; Dodds JN; Reif DM; DeWitt JC; Baker ES
    Chemosphere; 2024 Apr; 354():141654. PubMed ID: 38462188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative toxicometabolomics of perfluorooctanoic acid (PFOA) and next-generation perfluoroalkyl substances.
    Gebreab KY; Eeza MNH; Bai T; Zuberi Z; Matysik J; O'Shea KE; Alia A; Berry JP
    Environ Pollut; 2020 Oct; 265(Pt A):114928. PubMed ID: 32540561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonistic and potentiating effects of perfluoroalkyl substances (PFAS) on the Atlantic cod (Gadus morhua) peroxisome proliferator-activated receptors (Ppars).
    Søderstrøm S; Lille-Langøy R; Yadetie F; Rauch M; Milinski A; Dejaegere A; Stote RH; Goksøyr A; Karlsen OA
    Environ Int; 2022 May; 163():107203. PubMed ID: 35364415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.